Showing results (161-170 of 351) with videos related to
Sort By:
Pageof 36
Clinical Therapeutics|May 24, 2011
Single-dose, two-way crossover, bioequivalence study of Mycophenolate mofetil 500 mg tablet under fasting conditions in healthy male subjectsShashank Patel, Vijay Chauhan, Jayanta Mandal, et al.Blood|July 5, 2017
Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuationKate J Newberry, Keyur Patel, Lucia Masarova, et al.Antiviral Therapy|July 26, 2005
The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNAKeyur Patel, Jeff Albrecht, Erin Owens, et al.Genetic Testing and Molecular Biomarkers|March 30, 2013
Validation of standards for quantitative assessment of JAK2 c.1849G>T (p.V617F) allele burden analysis in clinical samplesPaul Collier, Keyur Patel, Paul Waeltz, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 1, 2012
Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infectionElliot B Tapper, Eric B Cohen, Keyur Patel, et al.Complementary Therapies in Clinical Practice|July 13, 2010
The use of complementary and alternative medicine by patients with chronic hepatitis CJacqueline A Richmond, Donald E Bailey, Keyur Patel, et al.Gastroenterology|February 24, 2010
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirinJeanette J McCarthy, Josephine H Li, Alexander Thompson, et al.Antiviral Therapy|December 14, 2011
Open-label phase 1b pilot study to assess the antiviral efficacy of simvastatin combined with sertraline in chronic hepatitis C patientsKeyur Patel, Seng G Lim, Chow W Cheng, et al.Journal of Hepatology|May 5, 2004
The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patientsHeather M Patton, Keyur Patel, Cynthia Behling, et al.Hepatology (Baltimore, Md.)|January 28, 2006
HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis CKeyur Patel, Suzanne Norris, Lauralynn Lebeck, et al.Pageof 36